An open-label, Multinational, Phase IIIb Study to Evaluate Patient and Satisfaction, Safety and Efficacy of Subcutaneous Administration of Trastuzumab in Patients With HER2-Positive Early Breast Cancer (ML28851) in Adjuvant/Neo-Adjuvant Setting

Yazar
Alsalef, K.
Ozguroglu, M.
Errihani, H.
Belbaraka, R.
Goktas, B.
Cicin, I.
Oukkal, M.
Mahfouf, H.
Mezlini, A.
Larbaoui, B.
Slim, B. A.
Uslu, R.
Üst veri
Tüm öğe kaydını göster
Bağlantı
http://hdl.handle.net/20.500.12627/114761
https://doi.org/10.1016/s0959-8049(18)30535-5
Koleksiyonlar